CoChat
Sign Up
Cited by 33

The DOI matches its Crossref record.

Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies

Badran, Mohamed M., Harisa, Gamaleldin I., AlQahtani, Saeed A., Alanazi, Fars K., Zoheir, Khairy M.A.·2016·Journal of Drug Delivery Science and Technology
DOI 10.1016/j.jddst.2016.01.004
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jddst.2016.01.004

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 43

  1. Abdel Mouez, 2014, Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres, Eur. J. Pharm. Sci., 51, 59, 10.1016/j.ejps.2013.08.029 · DOI
  2. Abdel-Hamid, 2012, ultra performance liquid chromatography determination of pravastatin sodium in erythrocytes, Asian J. Chem., 24, 584
  3. Anitha, 2014, Chitin and chitosan in selected biomedical applications, Prog. Polym. Sci., 39, 1644, 10.1016/j.progpolymsci.2014.02.008 · DOI
  4. Azadi, 2013, Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization, Int. J. Biol. Macromol., 62, 523, 10.1016/j.ijbiomac.2013.10.004 · DOI
  5. Bahreini, 2014, Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study, Nanoscale Res. Lett., 9, 340, 10.1186/1556-276X-9-340 · DOI
  6. Bhattarai, 2010, Chitosan-based hydrogels for controlled, localized drug delivery, Adv. Drug Deliv. Rev., 62, 83, 10.1016/j.addr.2009.07.019 · DOI
  7. Coimbra, 2010, Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation, J. Control. Release, 148, 303, 10.1016/j.jconrel.2010.09.011 · DOI
  8. Dash, 2010, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm., 67, 217
  9. Deepa, 2014, Versatile carboxymethyl chitin and chitosan nanomaterials: a review, WIREs Nanomed. Nanobiotechnol., 6, 574, 10.1002/wnan.1301 · DOI
  10. Ding, 2011, Facile preparation of a cationic poly(amino acid) vesicle for potential drug and gene co-delivery, Nanotechnology, 22, 1, 10.1088/0957-4484/22/49/494012 · DOI
  11. Dong, 2013, Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers, Carbohydr. Polym., 94, 940, 10.1016/j.carbpol.2013.02.013 · DOI
  12. Fan, 2012, Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique, Coll. Surf. B Biointerfaces, 90, 21, 10.1016/j.colsurfb.2011.09.042 · DOI
  13. Fröhlich, 2012, The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles, Int. J. Nanomed., 7, 5577, 10.2147/IJN.S36111 · DOI
  14. Ghori, 2014, Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices, Int. J. Pharm., 465, 405, 10.1016/j.ijpharm.2014.02.028 · DOI
  15. Graf, 2008, Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma, Digestion, 78, 34, 10.1159/000156702 · DOI
  16. Hamidi, 2008, Hydrogel Nanoparticles Drug Deliv., 60, 1638
  17. Hamidi, 2010, Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery, J. Pharm. Sci., 100, 1702, 10.1002/jps.22395 · DOI
  18. Harisa, 2016, Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer, Saudi Pharm. J., 24, 74, 10.1016/j.jsps.2015.03.024 · DOI
  19. Huading, 2013, Porous chitosan scaffolds with embedded Hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation, PLoS One, 8, e69950, 10.1371/journal.pone.0069950 · DOI
  20. Katz, 2005, Therapy insight: potential of statins for cancer chemoprevention and therapy, Nat. Clin. Pract. Oncol., 2, 82, 10.1038/ncponc0097 · DOI
  21. Kawata, 2001, Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomised controlled trial, Br. J. Cancer, 84, 886, 10.1054/bjoc.2000.1716 · DOI
  22. Kivisto, 2007, Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans, Pharm. Res., 24, 239, 10.1007/s11095-006-9159-2 · DOI
  23. Lee, 2004, Physicochemical properties and blood compatibility of acylated chitosan nanoparticles, Carbohydr. Polym., 58, 371, 10.1016/j.carbpol.2004.06.033 · DOI
  24. Lee, 2011, Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations, J. Natl. Cancer Inst., 103, 674, 10.1093/jnci/djr070 · DOI · Paper page
  25. Lifeng, 2006, In vivo antitumor activity of chitosan nanoparticles, Bioorg. Med. Chem. Lett., 16, 4243, 10.1016/j.bmcl.2006.05.078 · DOI
  26. Benito-Miguel, 2015, Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line, Photodiagnosis Photodyn. Ther., 12, 466, 10.1016/j.pdpdt.2015.05.001 · DOI
  27. Menter, 2011, Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites, PLoS One, 6, e28813, 10.1371/journal.pone.0028813 · DOI
  28. Mohammed, 2013, Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in vitro study, J. Pharm. Technol. Drug Res.
  29. Montori, 2014, Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease, J. Am. Med. Assoc., 311, 465, 10.1001/jama.2014.110 · DOI
  30. Prabaharan, 2015, Chitosan-based nanoparticles for tumor-targeted drug delivery, Int. J. Biol. Macromol., 72C, 1313, 10.1016/j.ijbiomac.2014.10.052 · DOI
  31. Prabhu, 2015, Polymeric nanoparticles for targeted treatment in oncology: current insights, Int. J. Nanomed., 5, 161
  32. Ramezani, 2009, The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes, Coll. Surf. B Biointerfaces, 72, 1, 10.1016/j.colsurfb.2009.03.018 · DOI
  33. Riekes, 2011, Evaluation of oral carvedilol microparticles prepared by simple emulsion technique using poly (3-hydroxybutyrate-co-3- hydroxyvalerate) and polycaprolactone as polymers, Mater. Sci. Eng. C, 31, 962, 10.1016/j.msec.2011.02.017 · DOI
  34. Smith, 2012, Anticancer activity of the cholesterol exporter ABCA1 gene, Cell Rep., 27, 580, 10.1016/j.celrep.2012.08.011 · DOI
  35. Sultana, 2013, Nanoparticles-mediated drug delivery approaches for cancer targeting: a review, J. Drug Target., 21, 107, 10.3109/1061186X.2012.712130 · DOI
  36. Trapani, 2011, Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery, Int. J. Pharm., 419, 296, 10.1016/j.ijpharm.2011.07.036 · DOI · Paper page
  37. Tummala, 2015, Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer, Saudi Pharm. J., 23, 308, 10.1016/j.jsps.2014.11.010 · DOI
  38. Wilson, 2010, Chitosan nanoparticlesasa new delivery system for the anti-Alzheimer drug tacrine, Nanomed. Nanotechnol. Biol. Med., 6, 144, 10.1016/j.nano.2009.04.001 · DOI
  39. Wong, 2002, HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis, Leukemia, 16, 508, 10.1038/sj.leu.2402476 · DOI
  40. Xia, 2011, Biological activities of chitosan and chitooligosaccharides, Food Hydrocoll., 25, 170, 10.1016/j.foodhyd.2010.03.003 · DOI
  41. Yokoi, 2014, Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments, Cancer Lett., 345, 48, 10.1016/j.canlet.2013.11.015 · DOI
  42. Zaki, 2012, Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium, AAPS Pharm. Sci. Tech., 13, 411, 10.1208/s12249-012-9758-7 · DOI
  43. Zhou, 2007, Preparation, characterization and anticancer effect of chitosan nanoparticles, J. Clin. Rehabil. Tissue Eng. Res., 11, 9688

Cited by

Sorted by citations

Metadata

Authors
Badran, M. M., Harisa, G. I., AlQahtani, S. A., Alanazi, F. K., & Zoheir, K. M. A.
ORCID
Badran, Mohamed M.
Venue
Journal of Drug Delivery Science and Technology
Publisher
Elsevier BV
Published
2016-04
Volume
32
Pages
1-9
ISSN
1773-2247
DOI
10.1016/j.jddst.2016.01.004
Cited by
33
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
King Saud University (G-2015-1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review